Caprock Group LLC Takes $714,000 Position in Agilent Technologies, Inc. $A

Caprock Group LLC bought a new position in shares of Agilent Technologies, Inc. (NYSE:A) during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund bought 5,682 shares of the medical research company’s stock, valued at approximately $714,000.

Other hedge funds have also recently bought and sold shares of the company. Norges Bank bought a new stake in shares of Agilent Technologies in the second quarter valued at about $395,088,000. AQR Capital Management LLC lifted its position in shares of Agilent Technologies by 424.1% in the 2nd quarter. AQR Capital Management LLC now owns 2,041,826 shares of the medical research company’s stock worth $240,956,000 after acquiring an additional 1,652,244 shares during the period. Ameriprise Financial Inc. increased its position in shares of Agilent Technologies by 132.2% during the second quarter. Ameriprise Financial Inc. now owns 2,354,111 shares of the medical research company’s stock valued at $277,807,000 after purchasing an additional 1,340,161 shares during the period. Massachusetts Financial Services Co. MA raised its stake in shares of Agilent Technologies by 10.7% in the second quarter. Massachusetts Financial Services Co. MA now owns 13,227,387 shares of the medical research company’s stock valued at $1,560,964,000 after purchasing an additional 1,273,994 shares in the last quarter. Finally, Troy Asset Management Ltd lifted its position in Agilent Technologies by 74.3% in the second quarter. Troy Asset Management Ltd now owns 2,397,820 shares of the medical research company’s stock worth $282,967,000 after purchasing an additional 1,021,865 shares during the period.

Agilent Technologies Price Performance

Shares of NYSE A opened at $125.80 on Tuesday. The company has a market capitalization of $35.58 billion, a PE ratio of 27.53, a PEG ratio of 3.65 and a beta of 1.30. The company has a quick ratio of 1.52, a current ratio of 1.96 and a debt-to-equity ratio of 0.45. The stock’s 50 day moving average price is $137.51 and its 200-day moving average price is $135.61. Agilent Technologies, Inc. has a twelve month low of $96.43 and a twelve month high of $160.27.

Agilent Technologies (NYSE:A) last issued its quarterly earnings results on Monday, November 24th. The medical research company reported $1.59 EPS for the quarter, topping analysts’ consensus estimates of $1.58 by $0.01. The business had revenue of $1.86 billion for the quarter, compared to analyst estimates of $1.83 billion. Agilent Technologies had a return on equity of 25.20% and a net margin of 18.75%.Agilent Technologies’s quarterly revenue was up 9.4% compared to the same quarter last year. During the same period last year, the company posted $1.46 earnings per share. Agilent Technologies has set its Q1 2026 guidance at 1.350-1.380 EPS and its FY 2026 guidance at 5.860-6.000 EPS. On average, equities analysts anticipate that Agilent Technologies, Inc. will post 5.58 EPS for the current year.

Agilent Technologies Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, April 22nd. Shareholders of record on Tuesday, March 31st will be given a $0.255 dividend. The ex-dividend date of this dividend is Tuesday, March 31st. This represents a $1.02 annualized dividend and a yield of 0.8%. Agilent Technologies’s payout ratio is currently 22.32%.

Insiders Place Their Bets

In other news, VP Rodney Gonsalves sold 3,000 shares of the firm’s stock in a transaction that occurred on Wednesday, November 26th. The shares were sold at an average price of $154.99, for a total transaction of $464,970.00. Following the completion of the sale, the vice president owned 31,846 shares in the company, valued at $4,935,811.54. This trade represents a 8.61% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink.

Analysts Set New Price Targets

A has been the subject of a number of recent research reports. Weiss Ratings restated a “hold (c+)” rating on shares of Agilent Technologies in a research note on Monday, December 29th. Barclays upgraded shares of Agilent Technologies from an “equal weight” rating to an “overweight” rating and set a $165.00 price target for the company in a research note on Monday, December 15th. HSBC started coverage on Agilent Technologies in a research note on Tuesday, January 20th. They issued a “buy” rating and a $180.00 price objective on the stock. Bank of America raised their target price on Agilent Technologies from $150.00 to $165.00 and gave the stock a “neutral” rating in a research report on Tuesday, November 25th. Finally, UBS Group upped their price target on Agilent Technologies from $170.00 to $180.00 and gave the company a “buy” rating in a research report on Tuesday, November 25th. Two analysts have rated the stock with a Strong Buy rating, eleven have assigned a Buy rating and three have issued a Hold rating to the stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $164.50.

Agilent Technologies Profile

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.